2^nd Antiviral Conference

The four day conference will focus on Antiviral Research with a combination of plenary lectures, invited lectures and contributing talks which will be selected from the open abstract submissions (submissions can be uploaded upon registration). A broad range of topics will be covered focusing on the latest clinical practice, as well as the discovery and development of antiviral agents for the treatment and cure of various infectious agents. 

Key Sessions

• HIV (Treatment)
• HIV (Eradication)
• HBV
• HCV
• Respiratory Viruses
• Vector Borne Viruses
• Norovirus & Emerging Viruses

Our speakers will discuss the latest developments and cutting edge research and look to address the question “What is next for the industry?” The purpose of this conference is to provide a platform for discussion, collaboration and free exchange of ideas, allowing all participants to present their work either as a talk or in poster form. 

Confirmed Plenary Speakers

George Lau (Humanity and Health Liver Clinic, Hong Kong)
Massimo Levrero (Sapienza University of Rome)
Hiroaki Mitsuya (National Institutes of Health)
Johan Neyts (Rega Institute for Medical Research)
Mario Stevenson (University of Miami Miller School of Medicine) 

Confirmed Invited Speakers

Leda Bassit (Emory University)
Daria Hazuda (Merck)
Baek Kim (Emory University)
Brendan Larder (RDI)
Kenneth Powell (Reviral)

Educational Objectives

The conference will address the following learning objectives:

1. Update participants on the overall progress in antiviral research
2. Inform clinicians of their choices in patient treatments with existing licenced antiviral therapies
3. Describe the pipeline of new compounds in development and their likely impact on patient treatments
4. Enhance the understanding of participants of the development of resistance to antiviral drugs and the importance of treatment selection and adherence to the correct dosing regimens
5. Evaluate the unmet needs for antiviral drugs to guide both academic and industry participants in their choice of research topics
6. Help participants foresee the impact of the latest discoveries in virology on the search for new therapies.

Target Audience

This conference will look to bridge the gap between clinical practise, industry and academia and will actively encourage the participation MDs, clinicians, nurses, clinical lab directors, clinical service planners, academic researchers and pharmaceutical industry representatives.